Know Cancer

or
forgot password

Randomized, Controlled Trial Investigating the Effect of Preoperative Oral Immunonutrition on Complications and Length of Hospital Stay After Elective Surgery for Pancreatic Cancer


N/A
18 Years
N/A
Open (Enrolling)
Both
Pancreatic Cancer

Thank you

Trial Information

Randomized, Controlled Trial Investigating the Effect of Preoperative Oral Immunonutrition on Complications and Length of Hospital Stay After Elective Surgery for Pancreatic Cancer


Inclusion Criteria:



- Men and women referred to treatment at Surgical Gastroenterology Clinic C, Ward 2122
for pancreatic cancer

- Age > 18 years.

Exclusion Criteria:

- Age < 18 years

- Pregnant and lactating women

- Persons who cannot understand and/or speak Danish

- Renal dysfunction

- Milk allergy

- Participants are excluded if elective surgery is not indicated after all

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

Overall postoperative complications after major gastrointestinal (GI) elective surgery.

Outcome Time Frame:

Within the first 30 days after surgery

Safety Issue:

No

Principal Investigator

Jens R Andersen, Chief Phys., Ass. Prof.

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Copenhagen

Authority:

Denmark: "The National Ethical Commitee under The Ministry of health and prevention".

Study ID:

H-1-2012-146

NCT ID:

NCT01789073

Start Date:

February 2013

Completion Date:

Related Keywords:

  • Pancreatic Cancer
  • Postoperative
  • Complications
  • Elective
  • Surgery
  • GI surgery
  • Immunonutrition
  • Immune-enhancing
  • Immune-modulating
  • Nutrition
  • Pancreatic cancer
  • Postoperative complications and length of hospital stay after major gastrointestinal (GI) elective surgery.
  • Pancreatic Neoplasms

Name

Location